載入中
NASDAQHealthcareBiotechnology
最新資料
US$23.37
+US$0.99 · +4.42%
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
前收盤價
US$23.37
+US$0.99 · +4.42%
盤中時間採用ET。市場資料可能有所延遲。
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
日內區間
目前US$23.37
52週區間
目前US$23.37
盤中時間採用ET。市場資料可能有所延遲。
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
日內區間
目前US$23.37
52週區間
目前US$23.37
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI5052.17萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM3605.41萬0.05%787.4億 USD0.19%US$278.94+0.49%
State Street SPDR S&P Biotech ETFXBI3331.36萬0.34%98.74億 USD0.35%US$153.77+3.00%
Vanguard Extended Market ETFVXF1889.43萬0.02%954億 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO1266.59萬0.09%139.17億 USD0.24%US$356.78+0.94%
iShares Biotechnology ETFIBB1051.75萬0.10%108.2億 USD0.44%US$206.49+3.00%
Vanguard Russell 2000 ETFVTWO847.07萬0.05%180億 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA790.55萬0.04%218.24億 USD0.03%US$32.79+0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMState Street SPDR S&P Biotech ETFXBIVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOiShares Biotechnology ETFIBBVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
